Given that ATRA and AM580 bind to the RARα active conformation and are non-selective CMA inhibitors, and that disruption of NCoR1/RARα interaction inhibits CMA in cancer cells (Fig. 1H), we reasoned that small molecules that directly reduce the NCoR1/RARα interaction would cause a more selective inhibition of CMA activity. Here, RARA is linked to cancer.